Legal & General Group PLC Natera, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Natera, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 155,190 shares of NTRA stock, worth $24.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,190
Previous 155,190 -0.0%
Holding current value
$24.8 Million
Previous $19.7 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$97.75 - $129.67 $2.29 Million - $3.04 Million
-23,424 Reduced 13.11%
155,190 $19.7 Million
Q2 2024

Aug 14, 2024
BUY
$85.28 - $112.6 $4.2 Million - $5.54 Million
49,221 Added 38.04%
178,614 $19.3 Million
Q1 2024

Jul 01, 2024
BUY
$59.21 - $92.9 $900,702 - $1.41 Million
15,212 Added 13.32%
129,393 $11.8 Million
Q1 2024

May 14, 2024
SELL
$59.21 - $92.9 $1.05 Million - $1.65 Million
-17,759 Reduced 13.46%
114,181 $10.4 Million
Q4 2023

Feb 15, 2024
SELL
$37.55 - $62.64 $174,232 - $290,649
-4,640 Reduced 3.4%
131,940 $8.26 Million
Q3 2023

Nov 14, 2023
SELL
$43.4 - $62.52 $555,780 - $800,631
-12,806 Reduced 8.57%
136,580 $6.04 Million
Q2 2023

Aug 14, 2023
BUY
$47.08 - $55.16 $774,513 - $907,437
16,451 Added 12.38%
149,386 $7.27 Million
Q1 2023

May 15, 2023
SELL
$36.57 - $58.29 $213,385 - $340,122
-5,835 Reduced 4.2%
132,935 $7.38 Million
Q4 2022

Feb 14, 2023
BUY
$34.17 - $47.91 $450,360 - $631,453
13,180 Added 10.49%
138,770 $5.57 Million
Q3 2022

Nov 14, 2022
SELL
$36.93 - $56.68 $670,538 - $1.03 Million
-18,157 Reduced 12.63%
125,590 $5.5 Million
Q2 2022

Aug 22, 2022
BUY
$28.13 - $44.54 $614,837 - $973,510
21,857 Added 17.93%
143,747 $5.09 Million
Q1 2022

May 16, 2022
BUY
$30.32 - $91.33 $331,822 - $999,515
10,944 Added 9.86%
121,890 $4.96 Million
Q4 2021

Feb 14, 2022
BUY
$86.26 - $119.0 $1.23 Million - $1.7 Million
14,249 Added 14.74%
110,946 $10.4 Million
Q3 2021

Nov 15, 2021
BUY
$100.17 - $126.36 $1.21 Million - $1.52 Million
12,057 Added 14.25%
96,697 $10.8 Million
Q2 2021

Aug 12, 2021
BUY
$86.05 - $119.72 $1.87 Million - $2.6 Million
21,700 Added 34.48%
84,640 $9.61 Million
Q1 2021

May 17, 2021
SELL
$91.47 - $124.36 $39,789 - $54,096
-435 Reduced 0.69%
62,940 $6.39 Million
Q4 2020

Feb 12, 2021
BUY
$66.66 - $111.74 $706,929 - $1.19 Million
10,605 Added 20.1%
63,375 $6.31 Million
Q3 2020

Nov 13, 2020
SELL
$45.89 - $72.67 $177,364 - $280,869
-3,865 Reduced 6.82%
52,770 $3.81 Million
Q2 2020

Aug 14, 2020
BUY
$26.36 - $49.86 $315,133 - $596,076
11,955 Added 26.76%
56,635 $2.82 Million
Q1 2020

May 14, 2020
BUY
$17.27 - $40.17 $178,709 - $415,679
10,348 Added 30.14%
44,680 $1.35 Million
Q4 2019

Feb 13, 2020
BUY
$32.1 - $40.4 $112,638 - $141,763
3,509 Added 11.38%
34,332 $1.16 Million
Q3 2019

Nov 13, 2019
BUY
$25.38 - $34.89 $474,555 - $652,373
18,698 Added 154.21%
30,823 $1.01 Million
Q2 2019

Aug 14, 2019
BUY
$17.75 - $27.58 $105,470 - $163,880
5,942 Added 96.1%
12,125 $335,000
Q1 2019

May 15, 2019
BUY
$11.34 - $20.62 $4,048 - $7,361
357 Added 6.13%
6,183 $127,000
Q4 2018

Feb 15, 2019
BUY
$12.32 - $24.38 $9,067 - $17,943
736 Added 14.46%
5,826 $81,000
Q3 2018

Nov 20, 2018
SELL
$18.82 - $28.96 $4,705 - $7,240
-250 Reduced 4.68%
5,090 $122,000
Q2 2018

Aug 10, 2018
SELL
$8.79 - $19.98 $5,361 - $12,187
-610 Reduced 10.25%
5,340 $101,000
Q1 2018

May 17, 2018
SELL
$9.0 - $11.95 $20,565 - $27,305
-2,285 Reduced 27.75%
5,950 $55,000
Q4 2017

Feb 13, 2018
BUY
$8.99 - $14.31 $74,032 - $117,842
8,235
8,235 $74,000

Others Institutions Holding NTRA

# of Institutions
527
Shares Held
118M
Call Options Held
308K
Put Options Held
191K
View Full List

About Natera, Inc.

NTRA Quotes by TradingView
  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email